Sage Therapeutics shares owned by Farallon Capital Management
Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Farallon Capital Management
from 13F filings
Historical chart of Farallon Capital Management investment in Sage Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Sage Therapeutics by Farallon Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $390k | 43k | 9.12 |
| 2025-03-31 | $340k | 43k | 7.95 |
| 2024-12-31 | $232k | 43k | 5.43 |
| 2024-09-30 | $309k | 43k | 7.22 |
| 2024-06-30 | $465k | 43k | 10.86 |
| 2024-03-31 | $802k | 43k | 18.74 |
| 2023-09-30 | $881k | 43k | 20.58 |
| 2021-03-31 | $26M | 345k | 74.85 |
| 2020-12-31 | $91M | 1.1M | 86.51 |
| 2020-09-30 | $64M | 1.1M | 61.12 |
| 2020-06-30 | $35M | 850k | 41.58 |
| 2020-03-31 | $19M | 675k | 28.72 |
| 2019-12-31 | $36M | 500k | 72.19 |
| 2019-09-30 | $52M | 373k | 140.29 |
| 2019-06-30 | $92M | 500k | 183.09 |
| 2019-03-31 | $95M | 600k | 159.05 |
| 2018-12-31 | $38M | 400k | 95.79 |
| 2018-09-30 | $88M | 625k | 141.25 |
| 2018-06-30 | $98M | 625k | 156.53 |
| 2018-03-31 | $72M | 445k | 161.07 |
| 2017-12-31 | $66M | 400k | 164.71 |
| 2017-09-30 | $15M | 244k | 62.30 |
| 2017-06-30 | $8.0M | 100k | 79.64 |
More positions owned by Farallon Capital Management
View all positions for Farallon Capital Management